116918 ⎘
Hydrolases acting on peptide bonds, i.e. peptidases (3.4) Cysteine endopeptidases (3.4.22)
Sub-classes:METHODS OF TREATMENT COMPRISING IGG ANTIBODIES AND AN IDES PROTEASE
#2COMPOSITIONS AND METHODS FOR DIRECTED LIGAND ANTIBODY DEVELOPMENT
#3CYSTEINE PROTEASE
#4COMPOSITIONS AND METHODS FOR USING ENGINEERED DEUBIQUITINASES FOR PROBING UBIQUITIN-DEPENDENT CELLULAR PROCESSES
#5COMPOSITIONS AND METHODS FOR USING ENGINEERED DEUBIQUITINASES FOR PROBING UBIQUITIN-DEPENDENT CELLULAR PROCESSES
#6TRUNCATED POLYPEPTIDES HAVING PROTEIN LIGASE ACTIVITY AND METHODS OF PRODUCTION THEREOF
#7COMPOSITIONS AND METHODS FOR USING ENGINEERED DEUBIQUITINASES FOR PROBING UBIQUITIN-DEPENDENT CELLULAR PROCESSES
#8RECOMBINANT TYPE-I HUMANIZED COLLAGEN POLYPEPTIDE, AND PREPARATION METHOD THEREFOR AND USE THEREOF
#9COMPOSITIONS AND METHODS FOR USING ENGINEERED DEUBIQUITINASES FOR PROBING UBIQUITIN-DEPENDENT CELLULAR PROCESSES
#10COMPOSITIONS AND METHODS FOR USING ENGINEERED DEUBIQUITINASES FOR PROBING UBIQUITIN-DEPENDENT CELLULAR PROCESSES
#11Compositions and methods for using engineered deubiquitinases for probing ubiquitin-dependent cellular processes
#12CYSTEINE PROTEASE
#13LABELING OF ANTIBODIES
#14METHOD FOR CONSTITUTIVE MALT1 PROTEASE ACTIVATION
#15RNA-TRIGGERED PROTEIN CLEAVAGE AND APPLICATIONS BY THE CRISPR CAS7-11-CSX29 COMPLEX
#16RNA-TRIGGERED PROTEIN CLEAVAGE AND APPLICATIONS BY THE CRISPR CAS7-11-CSX29 COMPLEX
#17Crystal Structure of The Human G267s Calpain-5 Protease Core Domain and Its Use in Rational Drug Design for Identifying Inhibitors of Calpain-5
#18Compositions and methods for using engineered deubiquitinases for probing ubiquitin-dependent cellular processes
#19Compositions and methods for using engineered deubiquitinases for probing ubiquitin-dependent cellular processes
#20METHOD FOR PRODUCING BLOCKPOYMERS BY MEANS OF LINKING BLOCKS BY A TRANSPEPTIDASE, AND BLOCK POLYMERS OBTAINED BY TRANSPEPTIDASE LINKING
#21COMPOSITIONS AND METHODS FOR INCREASING OR ENHANCING TRANSDUCTION OF GENE THERAPY VECTORS AND FOR REMOVING OR REDUCING IMMUNOGLOBULINS
#22BACTERIAL TOXINS AND USES THEREOF AS RAS SPECIFIC PROTEASES FOR TREATING CELL PROLIFERATION DISEASES AND DISORDERS
#23COMPOSITIONS AND METHODS FOR MEASURING AND INHIBITING CALPAIN-5 ACTIVITY
#24CELLS FOR IMPROVED IMMUNOTHERAPY AND USES THEREOF
#25Enhanced CAR Tregs and Bi-Specific Antibodies for Induction of Immune Tolerance, Treating Autoimmune Diseases and Preventing Transplantation Rejection
#26COMPOSITIONS AND METHODS FOR INCREASING OR ENHANCING TRANSDUCTION OF GENE THERAPY VECTORS AND FOR REMOVING OR REDUCING IMMUNOGLOBULINS
#27NOVEL CAS12B ENZYMES AND SYSTEMS
#28BACTERIAL TOXINS AND USES THEREOF AS RAS SPECIFIC PROTEASES FOR TREATING CELL PROLIFERATION DISEASES AND DISORDERS
#29COMPOSITION COMPRISING A GENE VECTOR THAT SELECTIVELY DEPLETES P16 POSITIVE SENESCENT CELLS
#30Compositions and methods for using engineered deubiquitinases for probing ubiquitin-dependent cellular processes
#31ERYTHROID CELLS COMPRISING PHENYLALANINE HYDROXYLASE
#32PLATELETS COMPRISING EXOGENOUS POLYPEPTIDES AND USES THEREOF
#33Composition comprising a gene vector that selectively depletes P16 positive senescent cells
#34ERYTHROID CELLS COMPRISING ARGINASE
#35ERYTHROID CELLS COMPRISING ARGININE DEIMINASE
#36Erythroid cells comprising phenylalanine ammonia lyase
#37ERYTHROID CELLS COMPRISING SERINE DEHYDRATASE
#38ERYTHROID CELLS COMPRISING LYSINE OXIDASE
#39LATIGLUTENASE (ALV003) FOR USE IN THE TREATMENT OF SYMPTOMATIC CELIAC DISEASE, GLUTEN INTOLERANCE OR GLUTEN SENSITIVITY
#40Methods and composition for detecting CAPN5
#41SYNTHETIC MEMBRANE-RECEIVER COMPLEXES
#42Group A streptococcus vaccine
#43Synthetic membrane-receiver complexes
#44Replication conditional virus that specifically kills senescent cells
#45PROTEINASE B AND LACTASE SOLUTION USING ITS PROPERTIES AND METHOD FOR PRODUCING THE SAME
#46Method for producing a protein hydrolysate
#47Bacterial toxins and uses thereof as Ras specific proteases for treating cell proliferation diseases and disorders
#48Labeling of antibodies
#49SYNTHETIC MEMBRANE-RECEIVER COMPLEXES
#50SYNTHETIC MEMBRANE-RECEIVER COMPLEXES
#51Synthetic membrane-receiver complexes
#52SYNTHETIC MEMBRANE-RECEIVER COMPLEXES
#53SYNTHETIC MEMBRANE-RECEIVER COMPLEXES
#54Synthetic membrane-receiver complexes
#55Use of cysteine endoprotease for reducing cloudiness in drinks
#56Synthetic membrane-receiver complexes
#57Synthetic membrane-receiver complexes
#58TOBACCO PROTEASE GENES
#59Expression of chimeric KSAC protein and method of producing soluble proteins by high pressure
#60Group A vaccine
#61Method of predicting a response to an anti-tumor treatment
#62Methods and compositions for the display of polypeptides on the pili of Gram-positive bacteria
#63Formulation for oral administration of proteins
#64Enzyme formulation for use as food supplement
#65Methods of identifying compounds for the treatment of fibrosis by using S1PR5
#66Methods and pharmaceutical compositions for treating celiac disease and gluten intolerance
#67Enzymatic process
#68Synthetic membrane-receiver complexes
#69PILUS PROTEINS AND COMPOSITIONS
#70Formulation for Oral Administration of Proteins
#71Synzymes
#72USE OF ENGINEERED VIRUSES TO SPECIFICALLY KILL SENESCENT CELLS
#73Use of a cysteine protease of plasmodium vivax
#74METHODS FOR IMPROVING GUT HEALTH
#75Methods for improving gut health
#76Silicon Derivate Layers/Films Produced by Silicatein-Mediated Templating and Process for Making the Same
#77Methods and Compositions for the Display of Polypeptides on the Pili of Gram-Positive Bacteria
#78Formulation for oral administration of proteins
#79Enzymatic Process
#80Use of a cysteine protease of Plasmodium vivax
#81PROCESS FOR THE HYDROLYSIS OF MILK PROTEINS
#82Method for manufacturing proteoses derived from animal protein and manufacturing food containing the proteoses